Stage IIB Prostate Cancer Completed Phase 2 Trials for Bicalutamide (DB01128)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00589472Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerTreatment
NCT00108732A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerTreatment